We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.6B
AUM Growth
-$57.7M
Cap. Flow
-$90.7M
Cap. Flow %
-5.69%
Top 10 Hldgs %
17.06%
Holding
1,655
New
414
Increased
301
Reduced
390
Closed
477

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$10.1M
2
CEG icon
Constellation Energy
CEG
+$9.73M
3
AMZN icon
Amazon
AMZN
+$8.28M
4
SMAR
Smartsheet Inc.
SMAR
+$7.44M
5
NVDA icon
NVIDIA
NVDA
+$5.46M

Sector Composition

Rank Sector Weight
1 Technology 14.63%
2 Consumer Discretionary 10.41%
3 Healthcare 8.03%
4 Communication Services 6.75%
5 Financials 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMVP icon
1151
PMV Pharmaceuticals
PMVP
$63.5M
$43.3K ﹤0.01%
28,700
-8,400
-23% -$13.3K
IVAC
1152
DELISTED
Intevac Inc
IVAC
$42.9K ﹤0.01%
+12,607
New +$39.8K
AQST icon
1153
Aquestive Therapeutics
AQST
$550M
$42.5K ﹤0.01%
11,932
-4,576
-28% -$21.1K
SLND icon
1154
Southland Holdings
SLND
$32.8M
$41K ﹤0.01%
12,612
WHWK
1155
Whitehawk Therapeutics
WHWK
$263M
$40.7K ﹤0.01%
12,897
-4,900
-28% -$11.1K
ZURA icon
1156
Zura Bio
ZURA
$551M
$40.5K ﹤0.01%
+16,200
New +$57.7K
ACCD
1157
DELISTED
Accolade Inc
ACCD
$39.3K ﹤0.01%
11,478
-1,564
-12% -$5.55K
VTYX
1158
DELISTED
Ventyx Biosciences
VTYX
$38.3K ﹤0.01%
17,499
-3,501
-17% -$7.93K
TELA icon
1159
TELA Bio
TELA
$43M
$36.5K ﹤0.01%
+12,087
New +$34K
ATYR
1160
aTyr Pharma
ATYR
$51.7M
$36.5K ﹤0.01%
+10,078
New +$30.5K
GUTS icon
1161
Fractyl Health
GUTS
$111M
$35.8K ﹤0.01%
+17,401
New +$40.5K
HLVX
1162
DELISTED
HilleVax
HLVX
$33.7K ﹤0.01%
+16,300
New +$30.6K
ORMP icon
1163
Oramed Pharmaceuticals
ORMP
$176M
$33.2K ﹤0.01%
13,735
-700
-5% -$1.66K
ORGO icon
1164
Organogenesis Holdings
ORGO
$247M
$32.6K ﹤0.01%
+10,200
New +$34.2K
TLRY icon
1165
Tilray
TLRY
$612M
$31.8K ﹤0.01%
2,390
NESRW
1166
DELISTED
National Energy Services Reunited Corp. Warrant
NESRW
$30.8K ﹤0.01%
+78,698
New +$45.8K
RMNI icon
1167
Rimini Street
RMNI
$466M
$30.7K ﹤0.01%
11,512
-200
-2% -$408
ALLK
1168
DELISTED
Allakos
ALLK
$30.3K ﹤0.01%
25,000
ACET icon
1169
Adicet Bio
ACET
$76.9M
$27.8K ﹤0.01%
1,807
-692
-28% -$13.1K
FFAI
1170
Faraday Future Intelligent Electric
FFAI
$11M
$26.4K ﹤0.01%
+72
New +$19.1K
CABA icon
1171
Cabaletta Bio
CABA
$455M
$25K ﹤0.01%
+11,001
New +$38.6K
BATL icon
1172
Battalion Oil
BATL
$31.3M
$17.2K ﹤0.01%
10,000
-45,388
-82% -$221K
SAIH
1173
SAIHEAT Ltd
SAIH
$39.5M
$16.9K ﹤0.01%
+1,461
New +$20.1K
ILLRW
1174
Triller Group Inc Warrant
ILLRW
$6.6K ﹤0.01%
+45,253
New +$8.02K
LONA
1175
LeonaBio Inc
LONA
$72M
$6.45K ﹤0.01%
1,100

Similar funds

Prelude Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Prelude Capital Management held 1,655 positions worth $1.6B, down 3.5% from $1.65B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Prelude Capital Management withdrew a net $90.7M in Q4 2024, closing 477 positions and reducing 390 holdings. Its most notable exit was Core Natural Resources Inc, an estimated $11.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Arcadium Lithium plc worth $4.41M.

  • Prelude Capital Management's largest Q4 2024 buy was Arcadium Lithium plc: 859,441 shares worth $4.41M.
  • Prelude Capital Management added most to Tesla in Q4 2024, an estimated $10.1M increase.
  • Prelude Capital Management's biggest Q4 2024 reduction was Reddit, cutting an estimated $9.58M.
  • Prelude Capital Management fully exited Core Natural Resources Inc in Q4 2024, selling an estimated $11.6M.
  • Prelude Capital Management's ten largest holdings make up 17% of its $1.6B portfolio in Q4 2024.
  • Prelude Capital Management opened 414 new positions and closed 477 in Q4 2024.
  • Prelude Capital Management's portfolio value fell 3.5% quarter-over-quarter to $1.6B.

Based on Prelude Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.